Logotype for Cegedim SA

Cegedim (CGM) Q2 2025 TU earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Cegedim SA

Q2 2025 TU earnings summary

16 Nov, 2025

Executive summary

  • H1 2025 revenue reached €322.5 million, up 1.1% reported and 2.8% like-for-like, driven by HR, health insurance, marketing, and digitalization activities.

  • Health insurance contributed 26% of revenue with 7% growth; business services accounted for 28% with strong HR and compliance-driven growth.

  • Deconsolidation of INPS in the UK and integration of Visiodent affected divisional results, with Software & Services revenue declining.

  • SBTi validated the group’s greenhouse gas reduction targets; credit facility converted to a sustainability-linked loan, lowering interest rates.

  • Major restructuring in pharmacy management software in France will result in about 100 job cuts to align costs with revenue and restore profitability.

Financial highlights

  • Like-for-like revenue growth was 2.8% for H1 2025; reported growth was 1.1%.

  • Flow division posted 7.8% reported growth, with third-party payer activities up 8.8%.

  • Data and marketing division grew 10.8% in H1, with strong performance in France and new client wins.

  • BPO division grew 8.1% in H1, driven by insurance and compliance services.

  • Cloud and support division had 0.3% growth, impacted by a major contract non-renewal.

Outlook and guidance

  • Like-for-like revenue growth for 2025 is expected in the 2%-4% range; recurring operating income is expected to increase.

  • Positive EBIT impact anticipated from the removal of INPS and Smart Rx restructuring, with exceptional charges booked in H1.

  • Guidance may be revised if geopolitical, macroeconomic, or currency risks worsen.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more